Associations between Notch-2, Akt-1 and HER2/neu expression in invasive human breast cancer: A tissue microarray immunophenotypic analysis on 98 patients

被引:22
作者
Florena, Ada Maria [1 ]
Tripodo, Claudio [1 ]
Guarnotta, Carla [1 ]
Ingrao, Sabrina [1 ]
Porcasi, Rossana [1 ]
Martorana, Anna [1 ]
Lo Bosco, Giosue [1 ]
Cabibi, Daniela [1 ]
Franco, Vito [1 ]
机构
[1] Univ Palermo, Dipartimento Patol Umana, IT-90127 Palermo, Italy
关键词
breast cancer; tissue microarray; HER2; Akt; Notch;
D O I
10.1159/000110024
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Objective: We aimed to investigate the existence of associations between well- established and newly recognized biological and phenotypic features of breast cancer involved in tumor progression and prognosis. Methods: Ninety- eight cases of invasive breast cancer were assessed for the immunohistochemical expression of estrogen and progesterone receptors, Ki-67, HER2, Akt-1, and Notch-2, using the tissue microarray technique. Data regarding tumor histotype, histological grade, tumor size and lymph node status were collected for each patient and included in the analysis. Results: Several significant associations between histological and/ or immunophenotypic features came from the analysis of our data. Positive associations were observed between estrogen and progesterone receptors, tumor grade and proliferation index, tumor grade and HER2, Akt-1 and estrogen receptors, and Notch-2 and HER2. Inverse associations were noted between hormone receptors and tumor grade, hormone receptors and HER2, Akt-1 and tumor grade, and Akt-1 and nodal invasion. Conclusions: Our results, showing the existence of a number of estrogen receptor-positive tumors with Akt-1 expression, better degree of differentiation, and no lymph node involvement, along with the presence of HER2-positive tumors with strong Notch-2 expression, support the role of Notch and Akt in breast cancer progression and suggest that they may also represent new appealing therapeutic targets. Copyright (c) 2007 S. Karger AG, Basel.
引用
收藏
页码:317 / 322
页数:6
相关论文
共 27 条
[1]  
Ahmad F, 1999, J IMMUNOL, V162, P4864
[2]   Tsetse eradication programme under fire [J].
Ahmad, K .
LANCET INFECTIOUS DISEASES, 2003, 3 (01) :4-4
[3]  
Altman DG, 1996, Practical Statistics for Medical Research
[4]   The Akt pathway in human breast cancer: a tissue-array-based analysis [J].
Bose, S ;
Chandran, S ;
Mirocha, JM ;
Bose, N .
MODERN PATHOLOGY, 2006, 19 (02) :238-245
[5]   Is there a role for Notch signalling in human breast cancer? [J].
Brennan, K ;
Brown, AMC .
BREAST CANCER RESEARCH, 2003, 5 (02) :69-75
[6]   Validation of tissue microarray technology in breast carcinoma [J].
Camp, RL ;
Charette, LA ;
Rimm, DL .
LABORATORY INVESTIGATION, 2000, 80 (12) :1943-1949
[7]   Rapamycin inhibits proliferation of estrogen-receptor-positive breast cancer cells [J].
Chang, Sharon B. ;
Miron, Penelope ;
Miron, Alexander ;
Iglehart, J. Dirk .
JOURNAL OF SURGICAL RESEARCH, 2007, 138 (01) :37-44
[8]   Immunohistochemical biomarkers in patients with early-onset breast carcinoma by tissue microarray [J].
Choi, DH ;
Kim, S ;
Rimm, DL ;
Carter, D ;
Haffty, BG .
CANCER JOURNAL, 2005, 11 (05) :404-411
[9]   Decreased levels of hypoxic cells in gefitinib treated ER+ HER-2 overexpressing MCF-7 breast cancer tumors are associated with hyperactivation of the mTOR pathway:: Therapeutic implications for combination therapy with rapamycin [J].
Dragowska, Wieslawa H. ;
Verreault, MaiTe ;
Yapp, Donald T. T. ;
Warburton, Corinna ;
Edwards, Lincoln ;
Ramsay, Euan C. ;
Huxham, Lynsey A. ;
Minchinton, Andrew I. ;
Gelmon, Karen ;
Bally, Marcel B. .
BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 (03) :319-331
[10]   PATHOLOGICAL PROGNOSTIC FACTORS IN BREAST-CANCER .1. THE VALUE OF HISTOLOGICAL GRADE IN BREAST-CANCER - EXPERIENCE FROM A LARGE STUDY WITH LONG-TERM FOLLOW-UP [J].
ELSTON, CW ;
ELLIS, IO .
HISTOPATHOLOGY, 1991, 19 (05) :403-410